Sort   by:  
 Page size 
UnknownEffect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.
Not available
S-EPMC4979167 | biostudies-literature
UnknownATF3 negatively regulates cellular antiviral signaling and autophagy in the absence of type I interferons.
Not available
S-EPMC5562757 | biostudies-literature
UnknownClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Not available
S-EPMC7255743 | biostudies-literature
UnknownAssociation of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Not available
S-EPMC8377563 | biostudies-literature
UnknownRacial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
Not available
S-EPMC8961318 | biostudies-literature
UnknownA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
Not available
S-EPMC7598547 | biostudies-literature
UnknownAssessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
Not available
S-EPMC8728628 | biostudies-literature
UnknownInterplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600 | biostudies-literature
UnknownSystemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185 | biostudies-literature
Sort   by:  
 Page size